A A AText only | Accessibility | Privacy and cookies

Browse site A to Z

Search results

Go To Advanced Search

You could also try: captivating (1), attractive (14), pleasing (1000), winning (61)

Azathioprine to treat neurological diseases - patient information

Description
This factsheet contains information about the use of azathioprine to treat neurological diseases, including how the treatment is given and the
Url
/Media/UHS-website-2019/Patientinformation/Medicinestherapiesandanaesthetics/Azathioprine-to-treat-neurological-diseases-3153-PIL.pdf

VenetoclaxHigh

Description
Chemotherapy Protocol Chronic Lymphocytic Leukaemia VENETOCLAX (high risk) Regimen • CLL – Venetoclax (high risk) Indication • Venetoclax is indicated for the treatment of
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/CLL/VenetoclaxHigh.pdf

Quality account 24-25 final

Description
QUALITY ACCOUNT 2024/25 QUALITY ACCOUNT Contents Part 1: Statement on quality from the chief executive 1.1 Chief executive’s stateme
Url
/Media/UHS-website-2019/Docs/About-the-Trust/Annual-reports-and-quality-accounts/quality-account-24-25-final1.pdf

Carboplatin-Docetaxel-Pertuzumab-Trastuzumab_IV-SC

Description
Chemotherapy Protocol BREAST CANCER CARBOPLATIN (AUC6)-DOCETAXEL- PERTUZUMABTRASTUZUMAB (IV/SC) Regimen • Breast Cancer – Carboplatin (AUC6)-Docetaxel-Pertuzumab-Trastuzumab (IV/SC) Indication
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Carboplatin-Docetaxel-Pertuzumab-Trastuzumab-IV-SC.pdf

Carboplatin-Docetaxel-Pertuzumab-Trastuzumab_IV

Description
Chemotherapy Protocol BREAST CANCER CARBOPLATIN (AUC 6)-DOCETAXEL-PERTUZUMABTRASTUZUMAB (IV) Regimen • Breast Cancer – Carboplatin (AUC6)-Docetaxel-Pertuzumab-Trastuzumab (IV) Indication • Neo
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Breastcancer/Carboplatin-Docetaxel-Pertuzumab-Trastuzumab-IV.pdf

Bendamustine-Obinutuzumab

Description
Chemotherapy Protocol Non-Hodgkin Lymphoma Bendamustine-Obinutuzumab Regimen • NHL – Bendamustine-Obinutuzumab Indication • Obinutuzumab in combination with bendamustine followed by obinutuzumab maintenance
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Lymphoma/Bendamustine-Obinutuzumab.pdf

MyelomaCTD21CyclophosphamideDexamethasoneThalidomide(CTD)Ver1

Description
Chemotherapy Protocol MULTIPLE MYELOMA CTD (21)-CYCLOPHOSPHAMIDE-DEXAMETHASONE-THALIDOMIDE (21 days) There are multiple versions of th
Url
/Media/UHS-website-2019/Docs/Chemotherapy-SOPs1/Myeloma/MyelomaCTD21CyclophosphamideDexamethasoneThalidomideCTDVer1.pdf

Papers Trust Board - 10 March 2026

Description
Date Time Location Chair Apologies Agenda Trust Board – Open Session 10/03/2026 9:00 - 13:00 Conference Room, Heartbeat Education
Url
/Media/UHS-website-2019/Docs/About-the-Trust/Trust-governance-and-corporate-docs/2026-Trust-documents/Papers-Trust-Board-10-March-2026.pdf

Pain relief at home - patient information

Description
This factsheet explains the different types of pain relief medications you may be prescribed and their common side effects.
Url
/Media/UHS-website-2019/Patientinformation/Surgery/Pain-relief-at-home-2940-PIL.pdf

Your child's medication: Venlafaxine for cataplexy - patient information

Description
This factsheet explains how your child should take venlafaxine as part of their treatment programme for narcolepsy with cataplexy.
Url
/Media/UHS-website-2019/Patientinformation/Childhealth/Your-childs-medication-Venlafaxine-for-cataplexy-3550-PIL.pdf
51 to 60 of 1000
Previous … 4 5 6 7 8 … Next